Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies Post author:Sam Post published:November 19, 2017 Post category:BioPharma Data will be submitted to health authorities globally, including the FDA and EMA. Source: BioSpace You Might Also Like Two Biotech Startups With a Shot at Reaching a Billion-Dollar Valuation September 26, 2017 Siemens Healthineers And HeartFlow Collaborate To Provide Solution That Has Potential To Lower Cardiac Care Costs March 16, 2017 Regeneron Heading for Another Hiring Ramp August 7, 2017
Siemens Healthineers And HeartFlow Collaborate To Provide Solution That Has Potential To Lower Cardiac Care Costs March 16, 2017
